Immunai, to map immune system for better diagnosis, disease treatment
Healthcare IT News - 14-May-2020This application of machine learning will soon speed up drug development
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
CEO and Co-founder, Immunai
Noam Solomon
I am the CEO and co-founder of a stealth-mode start-up company.
In the year 2018-2019, I was a post-doctoral researcher in the Mathematics department at MIT, hosted by Professor Larry Guth.
In the year 2017-2018, I was a post-doctoral researcher in the CMSA, the center of mathematical sciences and applications at Harvard University.
In my research I develop and apply tools from Algebra and Algebraic Geometry in the study of classical problems in Combinatorics, especially in Combinatorial Geometry.
I completed my Ph.D in the School of Computer Science in Tel-Aviv University, under the supervision of Professor Micha Sharir.
Here's my dissertation entitled Algebraic Techniques in Combinatorial and Computational Geometry
Before that, I completed a Ph.D in Pure Mathematics in Ben-Gurion University under the supervision of Professor Amnon Besser.
Here's my dissertation entitled P-adic Elliptic Polylogarithms and Arithmetic Applications
CONTACT INFORMATION
Email: noam.solom@gmail.com
Visit website: https://sites.google.com/site/noamsolomonswebpage/home/
See alsoDetails last updated 19-May-2020
This application of machine learning will soon speed up drug development